Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Boston Biomedical Associates | OTHER |
| Ocean State Clinical Coordinating Center | UNKNOWN |
Not provided
Not provided
Not provided
This is a single center, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Interventions | This patient pool shall be representative of the US population in term of the relative proportion of race/ethnicities. In addition, the population shall be enriched with patients above 60 year old as the target population of the PSP test is mostly the elderly. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Blood collection | Device | 9 mL K3-EDTA anticoagulated venous whole blood and 9 mL lithium heparin anticoagulated venous whole blood will be collected, processed in plasma and stored until the shipment to the sponsor for PSP measurement on the abioSCOPE device with IVD CAPSULE PSP kits |
| Measure | Description | Time Frame |
|---|---|---|
| Determination of reference range interval of PSP | To determine the reference range intervals of PSP values measured using abioSCOPE device with the PSP assay in a generally healthy population representative of the US population. | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Collect medical data of healthy volunteer | To collect medical data from the 150 study participants using a volunteer questionnaire | Day 1 |
| Obtain well characterised samples library to be used for future tests development |
Not provided
Inclusion Criteria:
Exclusion Criteria:
1) Current diagnosis, or history, of any underlying major medical condition determined by the investigator, including but not limited to:
Heart disease
Stroke
Renal disease
Liver disease
Pancreatic disease
Chronic obstructive pulmonary disorder
Bleeding disorders
Hypercalcitoninemia
HIV AIDS
Receiving antibiotic therapy
Suspected infection
Immunosuppression
2) Underwent procedures related to sepsis, or diagnosed with sepsis, within the last 12 months.
3) Current diagnosis of uncontrolled hypertension, hypotension, or diabetes.
4) Diagnosis of bacterial, fungal, or malaria infection within the last 3 months that required antimicrobial treatment.
5 )Experienced severe trauma, surgery, cardiac shock, or severe burn within the previous 3 months requiring medical care.
6) Current diagnosis of cancer within the last 12 months.
7) Received immunotherapy to stimulate or inhibit cytokines within the last 12 months.
8) Hospitalization for more than 24 hours within the last 3 months.
9) Reported as currently pregnant or nursing a child
10) Unable or unwilling to provide the required blood sample for testing.
11) Any other criteria that, in the opinion of the investigator, would render the participant unsuitable for inclusion in the trial.
Not provided
Not provided
Not provided
Not provided
150 generally healthy adults. This patient pool shall be representative of the US population in term of the relative proportion of race/ethnicities. In addition, the population shall be enriched with patients above 60 year old as the target population of the PSP test is mostly the elderly.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mercy Health St. Vincent | Toledo | Ohio | 43608 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| D012772 | Shock, Septic |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D001800 | Blood Specimen Collection |
| ID | Term |
|---|---|
| D013048 | Specimen Handling |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
Not provided
Not provided
Not provided
Not provided
Not provided
9 mL K3-EDTA anticoagulated venous whole blood and 9 mL lithium heparin anticoagulated venous whole blood will be collected, processed in plasma and stored until the shipment to the sponsor for PSP measurement on the abioSCOPE device with IVD CAPSULE PSP kits
|
Whole blood collection from 150 healthy subject to be used for future tests development.
| Day 1 |
| D013568 |
| Pathological Conditions, Signs and Symptoms |
| D012769 | Shock |
| D011677 | Punctures |
| D013514 | Surgical Procedures, Operative |
| D008919 | Investigative Techniques |